首页> 外国专利> A replication defective recombinant adenovirus comprising a antigenic determinant of Plasmodium falciparum wherein the antigenic determinant is SEQ ID 6

A replication defective recombinant adenovirus comprising a antigenic determinant of Plasmodium falciparum wherein the antigenic determinant is SEQ ID 6

机译:包含恶性疟原虫的抗原决定簇的复制缺陷型重组腺病毒,其中抗原决定簇为SEQ ID 6

摘要

Disclosed is a vaccine against malaria infections, based on recombinant adenoviruses viruses. The recombinant viral-based vaccine can be applied for immunization against Plasmodium infections, such as infections by P. falciparum. Codon-optimized circumsporozoite (CS) genes are disclosed (Seq Id No 4 and 6). Preferably, replication-defective adenoviruses are used, derived of serotypes (Ad11, Ad26, Ad34, Ad35, Ad48, Ad49 and Ad50) that encounter low titers of neutralizing antibodies.
机译:公开了一种基于重组腺病毒的抗疟疾感染的疫苗。重组的基于病毒的疫苗可用于针对疟原虫感染(例如恶性疟原虫感染)进行免疫。公开了密码子优化的环子孢子(CS)基因(序列号4和6)。优选地,使用复制品缺陷型腺病毒,其衍生自遇到低滴度的中和抗体的血清型(Ad11,Ad26,Ad34,Ad35,Ad48,Ad49和Ad50)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号